Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.05B | $8.62B | $9.87B | $9.56B | $9.18B | $8.15B | $9.09B | $8.50B |
| Cost of revenue | $2.81B | $2.74B | $2.98B | $3.08B | $3.01B | $2.97B | $3.11B | $3.31B |
| Gross profit | $7.24B | $5.87B | $6.89B | $6.48B | $6.17B | $5.18B | $5.97B | $5.19B |
| Gross margin | 72.0% | 68.2% | 69.8% | 67.8% | 67.2% | 63.6% | 65.7% | 61.1% |
| Research and development | $1.87B | $1.72B | $2.14B | $1.90B | $1.74B | $1.49B | $1.72B | $1.45B |
| Selling, general and administrative | $1.75B | $1.60B | $1.95B | $1.72B | $1.69B | $1.69B | $1.88B | $1.63B |
| Operating expenses | $3.73B | $3.21B | $4.17B | $3.95B | $3.51B | $4.00B | $3.66B | $3.15B |
| Operating income | $3.51B | $2.67B | $2.72B | $2.53B | $2.66B | $1.18B | $2.31B | $2.05B |
| Operating margin | 35.0% | 30.9% | 27.6% | 26.4% | 28.9% | 14.5% | 25.4% | 24.1% |
| EBITDA | $4.63B | $3.78B | $3.85B | $3.83B | $4.00B | $2.57B | $3.71B | $3.44B |
| Interest expense | −$673.00M | −$657.00M | −$653.00M | −$685.00M | −$694.00M | −$723.00M | −$747.00M | −$776.00M |
| Income before taxes | $2.77B | $2.08B | $1.51B | $3.92B | $1.57B | $1.97B | $782.00M | $3.10B |
| Income taxes | $393.00M | $265.00M | $181.00M | $705.00M | $136.00M | $243.00M | $155.00M | $271.00M |
| Net income | $2.38B | $1.82B | $1.33B | $3.22B | $1.43B | $1.73B | $627.00M | $2.83B |
| Net margin | 23.6% | 21.1% | 13.5% | 33.7% | 15.6% | 21.2% | 6.9% | 33.3% |
| EPS, basic | $4.40 | $3.37 | $2.48 | $5.98 | $2.66 | $3.22 | $1.17 | $5.27 |
| EPS, diluted | $4.37 | $3.34 | $2.45 | $5.93 | $2.65 | $3.20 | $1.15 | $5.22 |
| Diluted shares | 544.00M | 544.00M | 544.00M | 542.00M | 541.00M | 541.00M | 545.00M | 542.00M |
Figures describe Amgen shares, not any token. As of Aug 5, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.